Cargando…

An economic analysis of high-dose imatinib, dasatinib, and nilotinib for imatinib-resistant chronic phase chronic myeloid leukemia in China: A CHEERS-compliant article

BACKGROUND: The aim of the study was to test the cost-effectiveness of dasatinib compared to high-dose imatinib and nilotinib in Chinese patients who were diagnosed with imatinib-resistant chronic myeloid leukemia in the chronic phase (CML-CP). METHODS: A Markov model combined with clinical effectiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Bin, Liu, Maobai, Li, Te, Lin, Houwen, Zhong, Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5521894/
https://www.ncbi.nlm.nih.gov/pubmed/28723754
http://dx.doi.org/10.1097/MD.0000000000007445